Quest Diagnostics Incorporated
DGX
Rankning i aktier
#930
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Aktiekurs
$236.69
Senast synkroniserad: 2026-10-20
Marknadsvärde
$26.12B
Förändring (1 dag)
0.80%
Förändring (1 år)
28.19%
Land
US
Handel Quest Diagnostics Incorporated (DGX)
Kategori
Healthcare
Antal utestående aktier för Quest Diagnostics Incorporated (DGX)
Antal utestående aktier per June 2026: 110.00M
Enligt de senaste finansiella rapporterna och aktiekursen för Quest Diagnostics Incorporated är det aktuella antalet utestående aktier 110.00M. I slutet av December 2024 hade företaget 111.00M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Quest Diagnostics Incorporated (DGX) från 2000 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 110.00M | -0.90% |
| 2025 | 111.00M | 0.00% |
| 2024 | 111.00M | -0.89% |
| 2023 | 112.00M | -3.45% |
| 2022 | 116.00M | -7.20% |
| 2021 | 125.00M | -6.72% |
| 2020 | 134.00M | 0.00% |
| 2019 | 134.00M | -1.47% |
| 2018 | 136.00M | -0.73% |
| 2017 | 137.00M | -2.14% |
| 2016 | 140.00M | -2.78% |
| 2015 | 144.00M | -0.69% |
| 2014 | 145.00M | -4.61% |
| 2013 | 152.00M | -4.16% |
| 2012 | 158.60M | -0.06% |
| 2011 | 158.70M | -9.68% |
| 2010 | 175.70M | -5.49% |
| 2009 | 185.90M | -4.32% |
| 2008 | 194.30M | 0.55% |
| 2007 | 193.24M | -1.90% |
| 2006 | 196.99M | -2.40% |
| 2005 | 201.83M | -0.94% |
| 2004 | 203.75M | -1.56% |
| 2003 | 206.97M | 7.29% |
| 2002 | 192.91M | 3.40% |
| 2001 | 186.56M | 4.20% |
| 2000 | 179.04M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| 371.00M | 237.27% |
US
|
|
| 705.30M | 541.18% |
US
|
|
| 143.28M | 30.25% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 156.36% |
US
|
